Moreover, increasing evidence has been published showing that BCR/ABL induces reactive oxygen species (ROSs) causing oxidative damage to CML cells[8], and therefore a variety of DNA lesions, including the highly mutagenic double strand breaks (DSBs)[9], [10]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.